Creighton T Tuzon1, Diana Rigueur1, Amy E Merrill2,3. 1. Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA, 90033, USA. 2. Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, CA, 90033, USA. amerrill@usc.edu. 3. Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA. amerrill@usc.edu.
Abstract
PURPOSE OF REVIEW: Fibroblast growth factor receptor (FGFR) signaling regulates proliferation and differentiation during development and homeostasis. While membrane-bound FGFRs play a central role in these processes, the function of nuclear FGFRs is also critical. Here, we highlight mechanisms for nuclear FGFR translocation and the effects of nuclear FGFRs on skeletal development and disease. RECENT FINDINGS: Full-length FGFRs, internalized by endocytosis, enter the nucleus through β-importin-dependent mechanisms that recognize the nuclear localization signal within FGFs. Alternatively, soluble FGFR intracellular fragments undergo nuclear translocation following their proteolytic release from the membrane. FGFRs enter the nucleus during the cellular transition between proliferation and differentiation. Once nuclear, FGFRs interact with chromatin remodelers to alter the epigenetic state and transcription of their target genes. Dysregulation of nuclear FGFR is linked to the etiology of congenital skeletal disorders and neoplastic transformation. Revealing the activities of nuclear FGFR will advance our understanding of 20 congenital skeletal disorders caused by FGFR mutations, as well as FGFR-related cancers.
PURPOSE OF REVIEW: Fibroblast growth factor receptor (FGFR) signaling regulates proliferation and differentiation during development and homeostasis. While membrane-bound FGFRs play a central role in these processes, the function of nuclear FGFRs is also critical. Here, we highlight mechanisms for nuclear FGFR translocation and the effects of nuclear FGFRs on skeletal development and disease. RECENT FINDINGS: Full-length FGFRs, internalized by endocytosis, enter the nucleus through β-importin-dependent mechanisms that recognize the nuclear localization signal within FGFs. Alternatively, soluble FGFR intracellular fragments undergo nuclear translocation following their proteolytic release from the membrane. FGFRs enter the nucleus during the cellular transition between proliferation and differentiation. Once nuclear, FGFRs interact with chromatin remodelers to alter the epigenetic state and transcription of their target genes. Dysregulation of nuclear FGFR is linked to the etiology of congenital skeletal disorders and neoplastic transformation. Revealing the activities of nuclear FGFR will advance our understanding of 20 congenital skeletal disorders caused by FGFR mutations, as well as FGFR-related cancers.
Entities:
Keywords:
FGF2; FGFR1; FGFR2; Nuclear RTK, cancer; Skeletal development
Authors: Kai Yu; Jingsong Xu; Zhonghao Liu; Drazen Sosic; Jiansu Shao; Eric N Olson; Dwight A Towler; David M Ornitz Journal: Development Date: 2003-07 Impact factor: 6.868
Authors: Michal K Stachowiak; Xiaohong Fang; Jason M Myers; Star M Dunham; Ronald Berezney; Pamela A Maher; Ewa K Stachowiak Journal: J Cell Biochem Date: 2003-11-01 Impact factor: 4.429
Authors: Christopher Terranova; Sridhar T Narla; Yu-Wei Lee; Jonathan Bard; Abhirath Parikh; Ewa K Stachowiak; Emmanuel S Tzanakakis; Michael J Buck; Barbara Birkaya; Michal K Stachowiak Journal: PLoS One Date: 2015-04-29 Impact factor: 3.240
Authors: Lan Yu; Mervi Toriseva; Syeda Afshan; Mario Cangiano; Vidal Fey; Andrew Erickson; Heikki Seikkula; Kalle Alanen; Pekka Taimen; Otto Ettala; Martti Nurmi; Peter J Boström; Markku Kallajoki; Johanna Tuomela; Tuomas Mirtti; Inès J Beumer; Matthias Nees; Pirkko Härkönen Journal: Cancers (Basel) Date: 2022-01-07 Impact factor: 6.639